{"article_title": "Novartis to prepare the sale of its Roche stake: Sonntagszeitung", "article_keywords": ["roche", "sourcesa", "prepare", "worlds", "started", "spokesman", "stake", "sale", "novartis", "sonntagszeitung", "voting", "worth", "williams", "weekly"], "article_url": "http://www.thefiscaltimes.com/latestnews/2016/04/24/Novartis-prepare-sale-its-Roche-stake-Sonntagszeitung", "article_text": "The world's biggest prescription drugmaker started building up the stake - worth 33 percent of Roche's voting shares - as a basis for a possible merger more than a decade ago, but the plan never materialized.\n\nNovartis plans to sell the stake in a so-called order book process, having banks collect purchase offers within a predefined price range from selected investors, weekly Sonntagszeitung said, citing board and banking sources.\n\nA Novartis spokesman declined to comment on the report.\n\n(Reporting by Kirsti Knolle; Editing by Alison Williams)", "article_metadata": {"og": {"site_name": "The Fiscal Times", "description": "The world's biggest prescription drugmaker started building up the stake - worth 33 pe", "title": "Novartis to prepare the sale of its Roche stake: Sonntagszeitung", "url": "http://www.thefiscaltimes.com/latestnews/2016/04/24/Novartis-prepare-sale-its-Roche-stake-Sonntagszeitung", "image": "http://cdn.thefiscaltimes.com/sites/default/files/reuters/roche-results_1.jpg", "type": "article"}, "twitter": {"url": "http://www.thefiscaltimes.com/latestnews/2016/04/24/Novartis-prepare-sale-its-Roche-stake-Sonntagszeitung", "image": "http://cdn.thefiscaltimes.com/sites/default/files/reuters/roche-results_1.jpg", "card": "summary", "title": "The Fiscal Times"}, "viewport": "initial-scale=1, maximum-scale=1", "description": "The world's biggest prescription drugmaker started building up the stake - worth 33 pe", "generator": "Drupal 7 (http://drupal.org)"}, "article_summary": "Novartis plans to sell the stake in a so-called order book process, having banks collect purchase offers within a predefined price range from selected investors, weekly Sonntagszeitung said, citing board and banking sources.\nThe world's biggest prescription drugmaker started building up the stake - worth 33 percent of Roche's voting shares - as a basis for a possible merger more than a decade ago, but the plan never materialized.\nA Novartis spokesman declined to comment on the report.\n(Reporting by Kirsti Knolle; Editing by Alison Williams)"}